Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Vacuum Assisted Closure as a Treatment for Soft Tissue Injuries (VAC-ST)
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: University of Alabama at Birmingham
KCI USA, Inc.
Information provided by: University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT00582998
  Purpose

This project is designed as a prospective, randomized, comparative study evaluating the use of a negative pressure vacuum device in treating soft tissue injuries and the surgical incision following open reduction and internal fixation of calcaneus, tibial plateau, and pilon fractures.


Condition Intervention
Fracture of Calcaneus, Pilon or Tibial Plateau
Procedure: Standard Wound Dressing
Device: VAC

MedlinePlus related topics: Fractures
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Vacuum Assisted Closure as a Treatment for Soft Tissue Injuries Sustained as a Result of Calcaneus, Tibial Plateau and Pilon Fractures

Further study details as provided by University of Alabama at Birmingham:

Primary Outcome Measures:
  • Healing of Orthopaedic Trauma Extremity Wounds: Calcaneus, Pilon and Tibial Plateau Fractures [ Time Frame: Preoperative Phase: 10-21 days; Perioperative Phase: 7 days; Follow-up Phase: 24 months ] [ Designated as safety issue: No ]

Enrollment: 189
Study Start Date: June 2001
Estimated Study Completion Date: November 2008
Estimated Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1, A: Active Comparator
Standard post-operative wound dressing
Procedure: Standard Wound Dressing
Following repair of fracture of calcaneus, pilon or tibial plateau, a standard wound dressing is applied in the OR. Dressing is taken down post-op day 1 to evaluate draining, and if necessary, replaced. Dressing will be monitored for drainage every 48 hours until wound is clean, dry and intact.
2, B: Active Comparator
Vacuum Assisted Closure (VAC) device
Device: VAC
Following repair of fracture of calcaneus, pilon or tibial plateau, a Vacuum Assisted Closure (VAC) device is applied in the OR. VAC cannister is evaluated for drainage, and if necessary, replaced. VAC sponge will be monitored for drainage every 48 hours, replaced if needed, until wound is clean, dry and intact.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who have a closed calcaneus, tibial plateau or pilon fracture requiring open reduction and internal fixation.
  • Adult patients (19 years and older)

Exclusion Criteria:

  • No clinical evidence of infection
  • Patients unable or unwilling to give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00582998

Locations
United States, Alabama
The University of Alabama at Birmingham, Orthopaedic Trauma
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
University of Alabama at Birmingham
KCI USA, Inc.
Investigators
Principal Investigator: James P Stannard, MD The University of Alabama at Birmingham
  More Information

Publications:
Responsible Party: The University of Alabama at Birmingham ( James P. Stannard, MD, Professor of Surgery, Assoc. Director of Orthopaedic Surgery )
Study ID Numbers: F010316003, VAC2001-05
Study First Received: December 20, 2007
Last Updated: December 27, 2007
ClinicalTrials.gov Identifier: NCT00582998  
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
Vacuum Assisted Closure (VAC)
Calcaneus Fracture
Pilon Fracture
Tibial Plateau Fracture
Open Reduction and Internal Fixation

Study placed in the following topic categories:
Soft Tissue Injuries
Fractures, Bone
Wounds and Injuries
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on January 16, 2009